Moment of Clarity Highlights New Insights on TMS Therapy Success Rates in Mental Health Treatment

CORONA, CA – November 10, 2025 – PRESSADVANTAGE – Moment of Clarity has published a new resource, “TMS Therapy Success Rate ...

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

The FDA’s clearance of this expanded label enables access to Deep TMS™ for the critically important adolescent patient ...
MassDevice

FDA clears BrainsWay Deep TMS for depression in adolescents

BrainsWay announced today that the FDA granted a label expansion for its deep transcranial magnetic stimulation (Deep TMS) ...
MPR

BrainsWay Deep TMS Gains FDA Clearance for Adolescent Depression

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex.
InvestorsHub on MSN

Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression

Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for ...
TipRanks on MSN

Brainsway’s Deep TMS device granted FDA clearance in Major Depressive Disorder

BrainsWay (BWAY) announced that the FDA has granted a label expansion for the Deep Transcranial Magnetic Stimulation, or Deep TMS, system making ...

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

TRICARE coverage is primarily used by active and retired military service members and their eligible family members. This policy update, effective immediately, applies to TRICARE beneficiaries in the ...

New Resource on TMS Therapy for Anxiety Published by Moment of Clarity

Moment of Clarity has released a new resource titled “Transcranial Magnetic Stimulation for Anxiety“, now available on their ...